Factors Influencing Hospitalization Cost for Diabetic Patients in Traditional Chinese Medicine Hospitals in Qingyang City, China
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.2. Data Processing
2.3. Statistical Analysis
3. Results
3.1. The Results of Univariate Analysis of Length of Stay and Hospitalization Cost
3.2. The Results of Multivariate Analysis of Length of Stay and Hospitalization Cost
3.3. Path Analysis Results of Hospitalization Cost
4. Discussion
5. Research Deficiencies and Limitations
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Sapra, A.; Bhandari, P. Diabetes Mellitus. In StatPearls; StatPearls Publishing LLC.: Treasure Island, FL, USA, 2022. [Google Scholar]
- Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022, 45 (Suppl. S1), S17–S38. [CrossRef] [PubMed]
- IDF Diabetes Atlas. In Idf Diabetes Atlas; International Diabetes Federation: Brussels, Belgium, 2021.
- Tu, W.-J.; Xue, Y.; Nie, D. The Prevalence and Treatment of Diabetes in China From 2013 to 2018. JAMA 2022, 327, 1706. [Google Scholar] [CrossRef] [PubMed]
- Liu, C.; Yuan, Y.C.; Guo, M.N.; Xin, Z.; Chen, G.J.; Bentley, A.R.; Hua, L.; Zheng, J.P.; Ekoru, K.; Yang, J.K. Incidence of Type 1 Diabetes May Be Underestimated in the Chinese Population: Evidence from 21.7 Million People Between 2007 and 2017. Diabetes Care 2021, 44, 2503–2509. [Google Scholar] [CrossRef]
- Economic Costs of Diabetes in the, U.S. in 2017. Diabetes Care 2018, 41, 917–928. [CrossRef] [PubMed] [Green Version]
- Stedman, M.; Lunt, M.; Davies, M.; Livingston, M.; Duff, C.; Fryer, A.; Anderson, S.G.; Gadsby, R.; Gibson, M.; Rayman, G.; et al. Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: A detailed economic evaluation. BMJ Open 2020, 10, e033231. [Google Scholar] [CrossRef] [PubMed]
- Ma, R.C.W. Epidemiology of diabetes and diabetic complications in China. Diabetologia 2018, 61, 1249–1260. [Google Scholar] [CrossRef] [Green Version]
- Unnikrishnan, R.; Anjana, R.M.; Mohan, V. Diabetes mellitus and its complications in India. Nature reviews. Endocrinology 2016, 12, 357–370. [Google Scholar] [PubMed] [Green Version]
- Wang, J.; Ma, Q.; Li, Y.; Li, P.; Wang, M.; Wang, T.; Wang, C.; Wang, T.; Zhao, B. Research progress on TCM syndromes of diabetes mellitus. Biomed. Pharmacother. 2020, 121, 109565. [Google Scholar] [CrossRef]
- Gu, S.; Lai, L.H. Associating 197 Chinese herbal medicine with drug targets and diseases using the similarity ensemble approach. Acta Pharmacol. Sin. 2020, 41, 432–438. [Google Scholar] [CrossRef]
- Namdul, T.; Sood, A.; Ramakrishnan, L.; Pandey, R.M.; Moorthy, D. Efficacy of Tibetan medicine as an adjunct in the treatment of type 2 diabetes. Diabetes Care 2001, 24, 175–176. [Google Scholar] [CrossRef]
- Feng, D.; Serrano, R.; Ye, T.; Tang, S.; Duan, L.; Xu, Y.; Yang, J.; Liang, Y.; Chen, S.; Feng, Z.; et al. What Contributes to the Regularity of Patients with Hypertension or Diabetes Seeking Health Services? A Pilot Follow-Up, Observational Study in Two Sites in Hubei Province, China. Int. J. Environ. Res. Public Health 2016, 13, 1268. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gulumsek, E.; Keskek, S.O. Direct medical cost of nephropathy in patients with type 2 diabetes. Int. Urol. Nephrol. 2022, 54, 1383–1389. [Google Scholar] [CrossRef] [PubMed]
- Bao, X.Y.; Yang, C.; Fang, K.; Shi, M.Y.; Yu, G.P.; Hu, Y.H. Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing, China. J. Diabetes 2017, 9, 405–411. [Google Scholar] [CrossRef] [PubMed]
- Kjellberg, J.; Tikkanen, C.K.; Bagger, M.; Gaede, P. Short-term societal economic burden of first-incident type 2 diabetes-related complications-a nationwide cohort study. Expert Rev. Pharmacoecon. Outcomes Res. 2020, 20, 577–586. [Google Scholar] [CrossRef] [PubMed]
- Clarke, P.M.; Glasziou, P.; Patel, A.; Chalmers, J.; Woodward, M.; Harrap, S.B.; Salomon, J.A. Event rates, hospital utilization, and costs associated with major complications of diabetes: A multicountry comparative analysis. PLoS Med. 2010, 7, e1000236. [Google Scholar] [CrossRef] [Green Version]
- Zhang, P.; Lopez, R.; Attaway, A.H.; Georas, S.N.; Khatri, S.B.; Abi-Saleh, S.; Zein, J.G. Diabetes Mellitus Is Associated with Worse Outcome in Patients Hospitalized for Asthma. J. Allergy Clin. Immunol. 2021, 9, 1562–1569.e1. [Google Scholar] [CrossRef]
- Kabeya, Y.; Shimada, A.; Tsukada, N.; Atsumi, Y.; Higaki, M. Diabetes Affects Length of Stay and Hospital Costs for Elderly Patients with Pneumonia: An Analysis of a Hospital Administrative Database. Tokai J. Exp. Clin. Med. 2016, 41, 203–209. [Google Scholar]
- Aro, S.; Kangas, T.; Reunanen, A.; Salinto, M.; Koivisto, V. Hospital use among diabetic patients and the general population. Diabetes Care 1994, 17, 1320–1329. [Google Scholar] [CrossRef]
- Dall, T.M.; Mann, S.E.; Zhang, Y.; Quick, W.W.; Seifert, R.F.; Martin, J.; Huang, E.A.; Zhang, S. Distinguishing the economic costs associated with type 1 and type 2 diabetes. Popul. Health Manag. 2009, 12, 103–110. [Google Scholar] [CrossRef]
- Giorda, C.B.; Rossi, M.C.; Ozzello, O.; Gentile, S.; Aglialoro, A.; Chiambretti, A.; Baccetti, F.; Gentile, F.M.; Romeo, F.; Lucisano, G.; et al. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study. Nutr. Metab. Cardiovasc. Diseases 2017, 27, 209–216. [Google Scholar] [CrossRef]
- Sima, D.I.; Bondor, C.I.; Vereşiu, I.A.; Gâvan, N.A.; Borzan, C.M. Hospitalization Costs of Lower Limb Ulcerations and Amputations in Patients with Diabetes in Romania. Int. J. Environ. Res. Public Health 2021, 18, 2230. [Google Scholar] [CrossRef] [PubMed]
- Bala, C.; Rusu, A.; Ciobanu, D.; Roman, G. Length of Hospital Stay, Hospitalization Costs, and Their Drivers in Adults with Diabetes in the Romanian Public Hospital System. Int. J. Environ. Res. Public Health 2022, 19, 10035. [Google Scholar] [CrossRef] [PubMed]
Variable Attributes | Variable Codes | Variable Names | Dummy Variables | Variable Assignment |
---|---|---|---|---|
Endogenous variables | Y1 | Length of stay 1 | — | Ln (Length of stay) |
Y2 | Hospitalization cost 2 | — | Ln (Hospitalization cost) | |
Exogenous variables | X1 | Gender | — | 0 = Male, 1 = Female |
X2-0~X2-2 | Age | <45 (Reference) | 0, 0 | |
45~60 | 1, 0 | |||
>60 | 0, 1 | |||
X3 | Visit times | — | 0 = One time, 1 = Two times or more | |
X4 | Hospital level | — | 0 = Secondary hospitals, 1 = Tertiary hospitals | |
X5 | Surgery and Procedures | — | 0 = No, 1 = Yes | |
X6-0~X6-2 | Complications and comorbidities | With minor complications and complications (Reference) | 0, 0 | |
With complications and comorbidities | 1, 0 | |||
With serious complications and comorbidities | 0, 1 | |||
X7-0~X7-2 | Type of diabetes | Type 1 diabetes mellitus (Reference) | 0, 0 | |
Type 2 diabetes mellitus | 1, 0 | |||
Other types of diabetes mellitus 3 | 0, 1 | |||
X8 | DRG reform 4 | — | 0 = Before the reform, 1 = After the reform |
Variable | Variable Categories | N (%) | Length of Stay | Hospitalization Cost | ||
---|---|---|---|---|---|---|
M (P25, P75) 1 | Z/H-Value 2 /p-Value | M (P25, P75) | Z/H-Value /p-Value | |||
Gender | Male | 855 (67.43) | 12 (9, 15) | −2.50/0.024 | 5314.50 (3603.10, 6566.02) | −3.369/0.001 |
Female | 413 (32.57) | 11 (9, 14) | 4757.46 (2421.91, 6366.14) | |||
Age | <45 | 196 (15.46) | 12 (9, 15) | 0.452/0.798 | 5129.18 (3531.65, 6176.28) | 5.885/0.236 |
45~60 | 526 (41.48) | 11.5 (9, 15) | 5013.27 (2881.32, 6560.91) | |||
>60 | 546 (43.06) | 12 (9, 15) | 5301.25 (3189.56, 6744.10) | |||
Visit times | One time | 1247 (98.34) | 12 (9, 15) | −3.470/0.001 | 5173.08 (3060.79, 6518.52) | −2.856/0.004 |
Two times or more | 21 (1.66) | 15 (12, 18) | 6264.90 (5441.96, 7561.48) | |||
Length of stay | 1~7 | 119 (9.38) | 6 (4, 7) | 951.037 /<0.001 | 2663.37 (1832.32, 3783.57) | 520.768 /<0.001 |
8~14 | 787 (62.07) | 11 (9, 13) | 4567.46 (2470.38, 5752.93) | |||
15~21 | 305 (24.05) | 16 (15, 18) | 6879.41 (6028.12, 8088.07) | |||
22~28 | 43 (3.39) | 24 (23, 25) | 8552.96 (7435.97, 10191.01) | |||
29 and above | 14 (1.10) | 29.5 (29, 34) | 10970.54 (9234.02, 14119.92) | |||
Hospital level | Secondary hospitals | 250 (19.72) | 9 (8, 10.25) | −13.509 /<0.001 | 2109.95 (1875.26, 2352.06) | −23.466 /<0.001 |
Tertiary hospitals | 1018 (80.28) | 13 (10, 15) | 5721.91 (4542.43, 7013.67) | |||
Surgery and Procedures | No | 1258 (99.21) | 12 (9, 15) | −2.503/0.012 | 5210.09 (3174.24, 6548.89) | −4.244/<0.001 |
Yes | 10 (0.79) | 9 (8, 11.25) | 2103.74 (1662.75, 2374.13) | |||
Complications and comorbidities | With minor complications and comorbidities | 1210 (95.42) | 11.5 (9, 15) | 95.056/<0.001 | 5084.91 (3019.57, 6379.90) | 78.581/<0.001 |
With complications and comorbidities | 11 (0.87) | 19 (13, 21) | 8485.96 (3264.42, 10576.09) | |||
With serious complications and comorbidities | 47 (3.71) | 18 (17, 20) | 8214.58 (6782.10, 9747.09) | |||
Type of diabetes | Type 1 diabetes mellitus | 49 (3.86) | 10 (7.5, 13.5) | 7.895/0.019 | 4383.22 (3011.96, 5482.12) | 7.673/0.022 |
Type 2 diabetes mellitus | 952 (75.08) | 12 (9, 15) | 5171.61 (3058.24, 6515.02) | |||
Other types of Diabetes mellitus | 267 (21.06) | 12 (9, 15) | 5510.98 (3553.35, 6826.97) | |||
DRG reform | Before the reform | 831 (65.54) | 12 (10, 15) | −3.492/<0.001 | 5261.07 (3874.11, 6518.28) | −1.804/0.071 |
After the reform | 437 (34.46) | 11 (9, 14.5) | 4967.36 (2150.00, 6562.42) |
Variables | Ln (Length of Stay) | Ln (Hospitalization Cost) | ||||||
---|---|---|---|---|---|---|---|---|
B 1 | Beta 2 | t-Value | p-Value | B | Beta | t-Value | p-Value | |
Constant | 1.276 | 10.014 | <0.001 | 4.527 | 49.080 | <0.001 | ||
Gender (ref = Male) | ||||||||
Female | −0.008 | −0.010 | −0.366 | 0.714 | −0.010 | −0.008 | −0.618 | 0.537 |
Visit times (ref = One time) | ||||||||
Two times or more | 0.145 | 0.048 | 1.842 | 0.068 | −0.005 | −0.001 | −0.083 | 0.934 |
Hospital level (ref = Secondary hospitals) | ||||||||
Tertiary hospitals | 0.282 | 0.288 | 10.250 | <0.001 | 0.792 | 0.585 | 40.543 | <0.001 |
Surgery and Procedures (ref = No) | ||||||||
Yes | 0.010 | 0.002 | 0.084 | 0.933 | 0.009 | 0.002 | 0.111 | 0.911 |
Complications and comorbidities (ref = With minor complications and comorbidities) | ||||||||
With complications and comorbidities | 0.412 | 0.098 | 3.774 | <0.001 | 0.245 | 0.042 | 3.128 | 0.002 |
With serious complications and comorbidities | 0.416 | 0.202 | 7.702 | <0.001 | 0.131 | 0.046 | 3.325 | 0.001 |
Type of diabetes (ref = Type 1 diabetes mellitus) | ||||||||
Type 2 diabetes mellitus | 0.238 | 0.264 | 4.480 | <0.001 | 0.024 | 0.019 | 0.631 | 0.528 |
Other types of diabetes mellitus | 0.238 | 0.249 | 4.146 | <0.001 | 0.110 | 0.083 | 2.737 | 0.006 |
DRG reform (ref = Before the reform) | ||||||||
After the reform | 0.006 | 0.007 | 0.234 | 0.815 | ||||
Ln (Length of stay) | 0.676 | 0.489 | 33.644 | <0.001 |
Variables | Direct Effect | Indirect Effect | Total Effect | Ranking of Total Effect |
---|---|---|---|---|
Length of stay | 0.509 | -- | 0.509 | 2 |
Hospital level | 0.573 | 0.139 | 0.713 | 1 |
Type 2 diabetes mellitus | -- | 0.130 | 0.130 | 5 |
Other types of diabetes mellitus | 0.065 | 0.123 | 0.188 | 3 |
With complications and comorbidities | 0.041 | 0.048 | 0.089 | 6 |
With serious complications and comorbidities | 0.045 | 0.097 | 0.142 | 4 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chen, M.; Kong, F.; Su, B.; Wei, X.; Yang, J. Factors Influencing Hospitalization Cost for Diabetic Patients in Traditional Chinese Medicine Hospitals in Qingyang City, China. Int. J. Environ. Res. Public Health 2022, 19, 13859. https://doi.org/10.3390/ijerph192113859
Chen M, Kong F, Su B, Wei X, Yang J. Factors Influencing Hospitalization Cost for Diabetic Patients in Traditional Chinese Medicine Hospitals in Qingyang City, China. International Journal of Environmental Research and Public Health. 2022; 19(21):13859. https://doi.org/10.3390/ijerph192113859
Chicago/Turabian StyleChen, Mengen, Fanxin Kong, Bin Su, Xuexuan Wei, and Jingyu Yang. 2022. "Factors Influencing Hospitalization Cost for Diabetic Patients in Traditional Chinese Medicine Hospitals in Qingyang City, China" International Journal of Environmental Research and Public Health 19, no. 21: 13859. https://doi.org/10.3390/ijerph192113859